Purified & Clear Omega 3 Fish Oil 1000 mg

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best4.8 (4,630 ratings)
Format:Softgel Quantity: 120 Softgel(s) · 60 servings
Goals
$25.99 $0.43 per serving

Product analysis

59 out of 100

Purified & Clear Omega 3 Fish Oil 1000 mg provides EPA and DHA for support of blood-fat balance, with particularly favorable value for EPA. Incomplete form and oil-composition details make comparisons with other fish oils harder.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality21

The oil is described as ethyl esters, a less favorable omega-3 form for absorption. Some individual ingredient forms remain unspecified, leaving an incomplete picture of the preparation.

Ingredient Transparency59

EPA and DHA amounts are given separately, which is more useful than fish-oil weight alone. Other amount, form and oil-composition details are incomplete.

Value For Money84

The EPA content offers favorable value, while DHA is more moderately priced for the amount supplied. The cost advantage is therefore clearest for someone prioritizing EPA.

Customer Satisfaction91

Customer ratings are very positive across several thousand ratings. The feedback describes satisfaction without establishing effectiveness or safety.

Product Focus70

EPA and DHA give the formula a clear nutritional role in blood-fat balance. Its wider eye, joint and brain uses have more limited or context-dependent support.

Format
Softgel
Container
120 Softgel(s)
Per serving
$0.43
Customer rating
4.8 · 4,630 ratings
Report analysis

Goals

Impact
Highest effect
B+ Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 800 mg
Study evidence
Inflammation
Impact
High effect
C Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic
Fish Oil · 2000 mg
Study evidence
Fish Oil Supportive 68 studies
Cardiovascular Support
Impact
High effect
B+ Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Fish Oil · 2000 mg
Study evidence
Fish Oil Supportive 185 studies
Skin Health
Impact
High effect
A Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
Omega-3 · 1400 mg
Study evidence
Omega-3 Supportive 35 studies
Joint Health
Impact
High effect
B Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic
Omega-3 · 1400 mg
Study evidence
Omega-3 Supportive 40 studies
Impact
High effect
B Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 800 mg
Study evidence

Ingredients

IngredientAmount per servingScore
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Fish Oil (Anchovy)
2000 mg 76
Total Omega-3 Fatty Acids Ethyl Esters
1400 mg 74
Eicosapentaenoic Acid
800 mg 76
Docosahexaenoic Acid
400 mg 60
Gluten Free Adults 18–50
Report overview
D Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyA+ Value
A serving supplies 800 mg of EPA at a low cost per gram of EPA. The oil uses ethyl esters form. The oil is described as purified.
How this ingredient is rated

Active Ingredient Quality & Bioavailability48

The oil uses ethyl esters form. EPA makes up about 40% of the fish oil.
Molecular Form and Bioavailability
The oil uses ethyl esters form.
EPA Concentration Density
EPA makes up about 40% of the fish oil.
Oxidation Protection
Tocopherols are included to help protect the oil.

Dose, Safety & Label Transparency92

The serving provides 800 mg EPA and 400 mg DHA. The oil is described as purified; qualifying third-party contaminant testing is not noted.
Absolute EPA Dose per Serving
A serving provides 800 mg of EPA.
EPA-Centric Ratio
The serving contains 400 mg of DHA alongside EPA, giving more EPA than DHA.
Purity and Contaminant Testing
The oil is described as purified; qualifying third-party contaminant testing is not noted.

Value100

The cost per gram of EPA is low.
Price per Gram of EPA
The cost per gram of EPA is low.
D+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value
A serving provides 1200 mg of EPA and DHA combined at a low cost per gram. The oil is described as ethyl ester form. Independent testing or certification is not indicated in the available information.
How this ingredient is rated

Active Ingredient Quality & Bioavailability51

The oil is described as ethyl ester form. Independent testing or certification is not indicated in the available information.
Omega-3 Molecular Form
The oil is described as ethyl ester form.
Purification & Filtration Method
A purity claim is indicated, but process details are unspecified.
Third-Party Purity & Potency Verification
Independent testing or certification is not indicated in the available information.
Source & Sustainability
Fish Oil is listed on the nutrient panel.

Dose, Safety & Label Transparency88

The serving lists 800 mg EPA and 400 mg DHA. EPA and DHA make up about 60% of the fish oil.
Total Active Omega-3 Dose (EPA + DHA)
The serving provides 1200 mg of EPA and DHA combined.
Omega-3 Potency & Concentration
EPA and DHA make up about 60% of the fish oil.
EPA & DHA Individual Disclosure
The serving lists 800 mg EPA and 400 mg DHA.
Oxidation Protection (Stabilizers)
An antioxidant is indicated, but its name is unspecified.

Value100

The cost per gram of EPA and DHA is low.
Cost Per Gram of Active EPA + DHA
The cost per gram of EPA and DHA is low.
Omega-3 · 1400 mg OverallScore74
B- Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyA+ Value
A serving provides 1200 mg of EPA and DHA at a low cost per gram. EPA and DHA make up 60% of the oil. The fish oil is in ethyl ester form. A qualifying purity certification is not established.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

The fish oil is in ethyl ester form. The oil has a specified source and an antioxidant.
Molecular Form & Absorption Potential
The fish oil is in ethyl ester form.
Source Purity & Oxidative Protection
The oil has a specified source and an antioxidant.

Dose, Safety & Label Transparency64

A serving lists 800 mg of EPA and 400 mg of DHA. Together they make up 60% of the oil.
EPA & DHA Label Specificity
A serving lists 800 mg of EPA and 400 mg of DHA.
Active Ingredient Concentration
EPA and DHA make up 60% of the 2000 mg of oil.
Third-Party Purity Verification
No qualifying independent testing or purity certification is reported.

Value100

The cost per gram of EPA and DHA is low.
Price per 1000mg of EPA+DHA
The cost per gram of EPA and DHA is low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  2. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  3. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  4. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  5. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  6. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  7. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  8. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  9. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsEye Health forEPA (Eicosapentaenoic Acid)
  10. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsInflammation forFish Oil
  17. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsInflammation forFish Oil
  18. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsInflammation forFish Oil
  19. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsInflammation forFish Oil
  20. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledInflammation forFish Oil